Risk prediction is improved by adding markers of subclinical organ damage to SCORE

被引:213
|
作者
Sehestedt, Thomas [1 ,2 ]
Jeppesen, Jorgen [1 ]
Hansen, Tine W. [2 ,3 ]
Wachtell, Kristian [4 ]
Ibsens, Hans [5 ]
Torp-Petersen, Christian [6 ]
Hildebrandt, Per [1 ]
Olsen, Michael H. [1 ]
机构
[1] Glostrup Univ Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2600 Glostrup, Denmark
[2] Res Ctr Prevent & Hlth, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, DK-2650 Hvidovre, Denmark
[4] Rigshosp, Dept Cardiol, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Dept Internal Med, Holbaek, Denmark
[6] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark
关键词
Risk stratification; SCORE; Atherosclerotic plaques; Albuminuria; Pulse wave velocity; Left ventricular hypertrophy; CORONARY-HEART-DISEASE; BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; PRIMARY HYPERTENSION; AORTIC STIFFNESS; ROC CURVE; MICROALBUMINURIA;
D O I
10.1093/eurheartj/ehp546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and results In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% Cl 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR >= 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE >= 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE >= 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE >= 5% to include subjects with 1% <= SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07). Conclusion Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [21] An Improved Polygenic Risk Score for Risk Prediction in Breast Cancer
    Mavaddat, Nasim
    Michailidou, Kyriaki
    Kraft, Peter
    Garcia-Closas, Montserrat
    Simard, Jacques
    Easton, Douglas F.
    GENETIC EPIDEMIOLOGY, 2017, 41 (07) : 680 - 681
  • [22] Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
    Olsen, Michael H.
    Wachtell, Kristian
    Ibsen, Hans
    Lindholm, Lars
    Kjeldsen, Sverre E.
    Omvik, Per
    Nieminen, Markku S.
    Dahlof, Bjorn
    Okin, Peter M.
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2011, 29 (05) : 997 - 1004
  • [23] High Genetic Risk Score Is Associated with Increased Organ Damage in SLE
    Reid, Sarah
    Alexsson, Andrei
    Frodlund, Martina
    Sandling, Johanna K.
    Svenungsson, Elisabet
    Jonsen, Andreas
    Bengtsson, Christine
    Gunnarsson, Iva
    Bengtsson, Anders A.
    Rantapaa-Dahlqvist, Solbritt
    Eloranta, Maija-Leena
    Syvanen, Ann-Christine
    Sjowall, Christopher
    Ronnblom, Lars
    Leonard, Dag
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction
    Temtem, Margarida
    Mendonca, Maria Isabel
    Serrao, Marco Gomes
    Santos, Marina
    Sa, Debora
    Sousa, Francisco
    Soares, Carolina
    Rodrigues, Ricardo
    Henriques, Eva
    Freitas, Sonia
    Borges, Sofia
    Rodrigues, Mariana
    Guerra, Graca
    Freitas, Antonio Drumond
    Sousa, Ana Celia
    dos Reis, Roberto Palma
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (06) : 709 - 715
  • [25] The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?
    Wenger, N. K.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 366 - 367
  • [26] The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?
    Nanette K Wenger
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 366 - 367
  • [27] Improving cardiovascular risk prediction by adding parental history of myocardial infarction to the SCORE risk function
    Van Dis, I.
    Kromhout, D.
    Geleijnse, J. M.
    Boer, J. M. A.
    Verschuren, W. M. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 672 - 672
  • [28] Improving cardiovascular risk prediction by adding parental history of myocardial infarction to the SCORE risk function
    Van Dis, I.
    Kromhout, D.
    Geleijnse, J. M.
    Boer, J. M. A.
    Verschuren, W. M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 672 - 672
  • [29] Reading between the "subs": subclinical target organ damage and subclinical inflammation
    Terentes-Printzios, D.
    Vlachopoulos, C.
    Vyssoulis, G.
    Ioakeimidis, N.
    Xaplanteris, P.
    Aznaouridis, K.
    Christoforatou, E.
    Samentzas, A.
    Siama, A.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 483 - 483
  • [30] Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: Role of microalbuminuria
    Pontremoli, Roberto
    Leoncini, Giovanna
    Viazzi, Francesca
    Ratto, Elena
    Vaccaro, Valentina
    Falqui, Valeria
    Parodi, Angelica
    Conti, Novella
    Tomolillo, Cinzia
    Deferrari, Giacomo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : S112 - S114